Balaxi Pharmaceuticals fundamental analysis

BALAXI

26.7

0.38 (-1.40%)
Last updated on 13 May, 2026 | 12:08 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Balaxi Pharmaceuticals Fundamentals

P/E Ratio

16.68

P/B Ratio

0.66

Div. Yield

0

Sector P/E

43.08

Sector P/B

2.18

Sec. Div. Yield

79.78

Balaxi Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 16.68, compared to the sector average of 43.08. Its P/B Ratio stands at 0.66, while the sector’s is 2.18. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 79.78%.

Balaxi Pharmaceuticals Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Balaxi Pharmaceuticals reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost